782
ADVANCED IMAGING OF THE ABDOMEN
A
B
|
Figure 12.29. Stage 3B cervical carcinoma. Turbo spin echo (TSE) |
|
(A), fast low-angle shot (FLASH) (B) precontrast T1-weighted |
|
image, and (C) postcontrast 2D images reveal a cervical tumor |
|
with right pelvic wall involvement. The role and optimal |
|
sequences to be used for staging cervical carcinoma are evolving. |
|
(Source: van Vierzen PB, Massuger LF, Ruys SH, Barentsz JO. Fast |
|
dynamic contrast enhanced MR imaging of cervical carcinoma. |
|
Clin Radiol 1998;53:183–192, with permission from the Royal |
C |
College of Radiologists.) |
predictive value of 100% in detecting metasta- |
Therapy |
sis but is not common. Changing a metastatic |
Therapy of premalignant cervical lesions includes |
node size criterion influences the sensitivity |
|
and specificity. |
cryotherapy, laser vaporization, and excision. |
Lymphangiography, CT, and MRI are grossly |
Therapy for invasive cervical carcinoma is |
similar in their ability to detect lymph node |
generally surgical, except with extensive inva- |
metastasis from invasive cervical cancer; |
sion to surrounding structures when radiation |
because CT and MRI are less invasive, they are |
therapy is employed. Radiation therapy is also |
preferred. Abdominal US yield in detecting |
an option in those with pelvic recurrence after |
lymph node metastasis is low, so it has a limited |
initial surgery. Occasionally long survival is |
role. Even intraoperative laparoscopic US of |
achieved with radiotherapy for an unresectable |
pelvic lymph nodes detects only slightly more |
cervical carcinoma. Adding chemotherapy |
than half of metastatic nodes. |
improves prognosis in some. |
783
FEMALE REPRODUCTIVE ORGANS
A |
|
Figure 12.30. Cervical carcinoma. Transverse (A) and sagittal (B) |
|
MR images reveal a tumor infiltrating the uterine cervix (arrows). |
|
Right parametrial and myometrial invasion were suspected. |
|
(Courtesy of Egle Jonaitiene, M.D., Kaunas Medical University, |
|
Kaunas, Lithuania.) |
B |
Clinical stages IB and IIA are treated either by |
to differentiate between fibrosis and recur- |
|
radical hysterectomy and pelvic lymphadenopa- |
rence. Recurrence is either central around |
|
thy or radiation therapy, depending on tumor |
the cervix after radiotherapy, or at the vaginal |
|
size, while stages IIB and higher are in the |
cuff after hysterectomy, or at the pelvic side |
|
province of radiation and chemotherapy. Thus |
walls. |
|
a finding of parametrial invasion (stage IIB) |
Magnetic resonance imaging estimates tumor |
|
affects the therapeutic options. |
size rather accurately, and when performed |
|
Local tumor control with radiation therapy |
before and after chemotherapy it aids in evalu- |
|
depends on the site and the size of the recur- |
ating tumor response. Initially both tumor |
|
rence, the type of therapy, and the dose used. |
recurrence and changes secondary to surgery |
|
Survival for those with central recurrence |
and radiation are hypointense on T1and |
|
is longer than for those with pelvic wall |
hyperintense on T2-weighted MRI, but on a |
|
recurrence. |
longer term basis (about 1 year or so) fibrosis |
|
|
also becomes hypointense on T2-weighted |
|
Follow-Up |
images. Actual results are more complex, |
|
because after radiotherapy local tumor recur- |
||
|
||
Surgery and radiation distort the subsequent |
rence tends to have a heterogeneous T2- |
|
imaging appearance, and follow-up is simplified |
weighted signal, with inflammation during the |
|
if a posttherapy baseline study is obtained. |
early posttherapy period being hyperintense. |
|
Women who undergo laparotomy before radio- |
Later, cancer, degeneration, and necrosis are |
|
therapy appear to be at increased risk of devel- |
hyperintense, while fibrosis and granulation are |
|
oping small bowel obstruction. |
hypointense. Magnetic resonance imaging after |
|
Only a few studies discuss whether CT or MR |
radiation therapy achieves a lower specificity in |
|
is preferred for follow-up, although, similar to |
detecting tumor recurrence during the first 6 |
|
other pelvic tumors, a trend appears toward |
months after start of radiation therapy, but later |
|
greater MR use, as it appears to be better able |
sensitivity increases. |